The patient’s perspective in the pharmaceutical regulatory and access pathway: considerations and recommendations from the 2025 Patient Forum

Claudio Jommi, Fabio Amanti, Oriana Ciani, Francesco Damele, Massimo Di Maio, Antonella Di Lorenzo, Elisabetta Iannelli, Anna Lisa Mandorino, Andrea Marcellusi, Viviana Ruggieri, Annalisa Scopinaro, Rosy Amodeo, Giorgia Fedele, Cosetta Bianchi, Massimo Medaglia, Giuliano Buzzetti, Maria Cristina Carena

Open source

DOI: 10.33393/grhta.2026.3833
Published: 2026-10-26
Container: Global and Regional Health Technology Assessment
Publisher: Aboutscience Srl
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.33393/grhta.2026.3833,
  title = {The patient’s perspective in the pharmaceutical regulatory and access pathway: considerations and recommendations from the 2025 Patient Forum},
  author = {Claudio Jommi and Fabio Amanti and Oriana Ciani and Francesco Damele and Massimo Di Maio and Antonella Di Lorenzo and Elisabetta Iannelli and Anna Lisa Mandorino and Andrea Marcellusi and Viviana Ruggieri and Annalisa Scopinaro and Rosy Amodeo and Giorgia Fedele and Cosetta Bianchi and Massimo Medaglia and Giuliano Buzzetti and Maria Cristina Carena},
  year = {2026},
  journal = {Global and Regional Health Technology Assessment},
  doi = {10.33393/grhta.2026.3833},
  url = {https://doi.org/10.33393/grhta.2026.3833}
}

RIS

TY  - JOUR
TI  - The patient’s perspective in the pharmaceutical regulatory and access pathway: considerations and recommendations from the 2025 Patient Forum
AU  - Claudio Jommi
AU  - Fabio Amanti
AU  - Oriana Ciani
AU  - Francesco Damele
AU  - Massimo Di Maio
AU  - Antonella Di Lorenzo
AU  - Elisabetta Iannelli
AU  - Anna Lisa Mandorino
AU  - Andrea Marcellusi
AU  - Viviana Ruggieri
AU  - Annalisa Scopinaro
AU  - Rosy Amodeo
AU  - Giorgia Fedele
AU  - Cosetta Bianchi
AU  - Massimo Medaglia
AU  - Giuliano Buzzetti
AU  - Maria Cristina Carena
PY  - 2026
JO  - Global and Regional Health Technology Assessment
DO  - 10.33393/grhta.2026.3833
UR  - https://doi.org/10.33393/grhta.2026.3833
ER  -

APA

Jommi, C., Amanti, F., Ciani, O., Damele, F., Maio, M. D., Lorenzo, A. D., Iannelli, E., Mandorino, A. L., Marcellusi, A., Ruggieri, V., Scopinaro, A., Amodeo, R., Fedele, G., Bianchi, C., Medaglia, M., Buzzetti, G., & Carena, M. C. (2026). The patient’s perspective in the pharmaceutical regulatory and access pathway: considerations and recommendations from the 2025 Patient Forum. Global and Regional Health Technology Assessment. https://doi.org/10.33393/grhta.2026.3833

Source records

crossref · retrieved 2026-11-11T03:53:04.663Z